The psychosocial burden of psoriatic arthritis
Authors:
Open Access
- 1 December 2017
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 47 (3) , 351-360
Abstract
No abstract availableKeywords
Funding Information
- Novartis Pharmaceuticals Corporation
This publication has 92 references indexed in Scilit:
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialThe Lancet, 2013
- Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health‐related quality of lifeArthritis Care & Research, 2012
- Cardiovascular Risk in Patients with Psoriatic ArthritisInternational Journal of Rheumatology, 2012
- A randomized placebo-controlled trial of methotrexate in psoriatic arthritisRheumatology, 2012
- Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritisArthritis Care & Research, 2012
- Occurrence and correlates of fatigue in psoriatic arthritisAnnals of the Rheumatic Diseases, 2009
- Pain catastrophizing: a critical reviewExpert Review of Neurotherapeutics, 2009
- The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy peopleHealth and Quality of Life Outcomes, 2009
- Functional Assessment of Chronic Illness Therapy-Fatigue Scale is valid in patients with psoriatic arthritisAnnals of the Rheumatic Diseases, 2007
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006